首页> 外文期刊>Folia neuropathologica >Impact of L-DOPA treatment of patients with Parkinson’s disease on mononuclear subsets and phagocytosis in the peripheral blood
【24h】

Impact of L-DOPA treatment of patients with Parkinson’s disease on mononuclear subsets and phagocytosis in the peripheral blood

机译:L-DOPA治疗帕金森氏病对外周血单核亚群和吞噬作用的影响

获取原文
           

摘要

Until now, the question as to the role of immunological mechanisms in neuronal death of extrapyramidal cell systems in Parkinson’s disease (PD) has not been fully resolved. One of the approaches includes examination of circulating blood cells. In our studies on 24 PD patients, peripheral blood was studied before and after medication with L-DOPA compounds. Patients with PD demonstrated an increase in lymphocyte CD95/CD3 ratio as well as a considerable number of cells dead due to apoptotic processes. After treatment with L-DOPA, both the CD95/CD3 ratio, assumed to represent an antigen marker characteristic of apoptotic cells, and the number of cells dead due to apoptotic processes were found to be decreased. Thus, the findings indicate that levodopa treatment in PD has an impact on apoptotic processes and this should be taken into consideration as a positive event in the pathomechanism precipitated by this treatment.
机译:到目前为止,关于免疫学机制在帕金森氏病(PD)中锥体束外细胞系统神经元死亡中的作用的问题尚未完全解决。方法之一包括检查循环血细胞。在我们对24名PD患者的研究中,在使用L-DOPA化合物药物治疗前后对外周血进行了研究。 PD患者表现出淋巴细胞CD95 / CD3比值增加以及由于凋亡过程而导致大量细胞死亡。用L-DOPA处理后,发现被认为代表凋亡细胞的抗原标志物的CD95 / CD3比率和由于凋亡过程而死亡的细胞数量均被发现减少。因此,这些发现表明左旋多巴在PD中的治疗对凋亡过程有影响,应将其视为由该治疗引起的病理机制中的阳性事件。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号